Jin He, MD
Assistant Professor of Surgery
Languages: English, Chinese
Expertise: Bile Duct Cancer, Bile Duct Disease, Bile Duct Repair, Bile Duct Surgery, Bile Duct Tumors, Biliary Tract Surgery, Biliary Tree, Colorectal Metastases to the Liver, Distal Pancreatectomy, Gallbladder Cancer, Gastric Cancer, Gastrointestinal Cancers, Gastrointestinal Diseases, Hepatic Surgery, Hepatobiliary Disease, Hepatobiliary Malignancies, Hepatobiliary Surgery, Hepatocellular Cancer, Hepatopancreatobiliary Surgery, Hyperthermic Intraperitoneal Chemotherapy (HIPEC), Klatskin Tumors, Laparoscopic Adrenal Surgery , Laparoscopic Cholecystectomy, Laparoscopic Gallbladder Surgery, Laparoscopic Liver Surgery, Laparoscopic Pancreas Surgery, Liver Cancer, Liver Cysts, Liver Tumors, Minimally Invasive Surgery, Neuroendocrine Tumors, Pancreatic Cancer, Pancreatic Cysts, Pancreatic Disease, Pancreatic Surgery, Pancreatic Tumors, Pancreaticoduodenectomy, Retroperitoneal Sarcomas, Robotic Bilary Surgery, Robotic Liver Surgery, Robotic Pancreas Surgery, Stomach Cancer, Stomach Tumors, Surgical Oncology, Von Hippel-Lindau (VHL), Whipple Procedure.
Research Interests: Personalized treatment through stratifying pancreatic cancers on their genetic features; pancreatic cancer, liver tumors, pancreatic cysts, pancreatic cancer genetics.
Jin He, M.D., Ph.D., is an assistant professor of surgery at the Johns Hopkins University School of Medicine. He is a surgical oncologist specializing in tumors from the liver, gallbladder, bile ducts, pancreas, stomach, duodenum, and retroperitoneum. He performs open as well as minimally invasive (robotic and laparoscopic) surgery, including the Whipple procedure and hyperthermic intraperitoneal chemotherapy (HIPEC), a procedure used to treat peritoneal malignancy.
Dr. He received his medical degree from Beijing Medical University, one of China’s leading medical schools, and a Ph.D. in oncology from Fudan University, Shanghai Medical College. He completed the general surgery residency training at Johns Hopkins, followed by a Hopkins fellowship in complex general surgical oncology, one of the few US programs that is ACGME accredited.
A passionate foe of pancreatic cancer, Dr. He’s research focuses on personalized treatment through stratifying pancreatic cancers on their genetic features. He holds several patents in anti-cancer vascular targeting agents and has published numerous scientific articles in peer-reviewed journals.